BRTX vs CF · rev $401.0K vs P/E 12, rev $5.94B
BioRestorative Therapies Inc (BRTX) versus CF Industries Holdings Inc (CF) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
BRTX currently screens at market cap $10.2M. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Not investment advice. Open the BRTX and CF stock pages for the full models.
Not investment advice.